Mark Thursz
Imperial College London
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Mark Thursz as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 01:02 UTC. Open this list on ClinicalTrials.gov
- Ph2NCT03775109 · IL-1 Signal Inhibition in Alcoholic HepatitisImperial College London · completed · Alcoholic Hepatitis · study director
- Ph2NCT03452540 · Efficacy and Safety of Orally Administered DS102 in Patients With Acute Alcoholic HepatitisAfimmune · terminated · Severe Acute Decompensated Alcoholic Hepatitis · principal investigator
- Ph3NCT03069300 · N-ACetylcysteine to Reduce Infection and Mortality for Alcoholic HepatitisImperial College London · unknown · Alcoholic Hepatitis, Infection · principal investigator
- Ph1NCT02496897 · Phase I Safety and Immunogenicity of FP-02.2 in Chronic Hepatitis BAltimmune, Inc. · completed · Hepatitis B · principal investigator
- N/ANCT02129829 · PROLIFICA - West African Treatment Cohort for Hepatitis BImperial College London · completed · Hepatitis B, Chronic, Hepatocellular Carcinoma · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 01:02 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-12 01:02 UTC. The ranking covers the 200 most relevant of 16 PubMed records, and a shared surname and initials can bring in a namesake. All 16 on PubMed
- Prednisolone or pentoxifylline for alcoholic hepatitis.N Engl J Med · 2015652 citationsRCR 23.3
- In Patients With Severe Alcoholic Hepatitis, Prednisolone Increases Susceptibility to Infection and Infection-Related Mortality, and Is Associated With High Circulating Levels of Bacterial DNA.Gastroenterology · 2017160 citationsRCR 6.1
- Acceptability and feasibility of a screen-and-treat programme for hepatitis B virus infection in The Gambia: the Prevention of Liver Fibrosis and Cancer in Africa (PROLIFICA) study.Lancet Glob Health · 2016150 citationsRCR 6.0
- The effects of dietary supplementation with inulin and inulin-propionate ester on hepatic steatosis in adults with non-alcoholic fatty liver disease.Diabetes Obes Metab · 201983 citationsRCR 3.6
- 74 citationsRCR 2.7
- The effectiveness and cost-effectiveness of minimal access surgery amongst people with gastro-oesophageal reflux disease - a UK collaborative study. The REFLUX trial.Health Technol Assess · 200866 citationsRCR 2.5
- Steroids or pentoxifylline for alcoholic hepatitis (STOPAH): study protocol for a randomised controlled trial.Trials · 201364 citationsRCR 2.1
- Therapeutic vaccine IC41 as late add-on to standard treatment in patients with chronic hepatitis C.Vaccine · 200956 citationsRCR 1.4
- Mortality risk prediction of high-sensitivity C-reactive protein in suspected acute coronary syndrome: A cohort study.PLoS Med · 202246 citationsRCR 3.6
- Antinuclear antibodies (ANA) in chronic hepatitis C virus infection: correlates of positivity and clinical relevance.J Viral Hepat · 200444 citationsRCR 1.2